{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:23:23Z","timestamp":1777728203834,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25DA013582"],"award-info":[{"award-number":["R25DA013582"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25DA033211"],"award-info":[{"award-number":["R25DA033211"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25DA033211"],"award-info":[{"award-number":["R25DA033211"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25DA013582"],"award-info":[{"award-number":["R25DA013582"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5T32AI052074"],"award-info":[{"award-number":["5T32AI052074"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11606-020-05920-0","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T21:02:52Z","timestamp":1590613372000},"page":"2418-2426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5029-9384","authenticated-orcid":false,"given":"Simeon","family":"Kimmel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paxton","family":"Bach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander Y.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"5920_CR1","doi-asserted-by":"publisher","unstructured":"Springer SA, Korthuis PT, del Rio C. Integrating Treatment at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics in Medical Settings: A Call for Action After a National Academies of Sciences, Engineering, and Medicine Workshop. Ann Intern Med. 2018. doi:https:\/\/doi.org\/10.7326\/M18-1203","DOI":"10.7326\/M18-1203"},{"issue":"8","key":"5920_CR2","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","volume":"174","author":"JM Liebschutz","year":"2014","unstructured":"Liebschutz JM, Crooks D, Herman D, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369-1376. doi:https:\/\/doi.org\/10.1001\/jamainternmed.2014.2556","journal-title":"JAMA Intern Med."},{"key":"5920_CR3","doi-asserted-by":"publisher","unstructured":"Shanahan CW, Beers D, Alford DP, Brigandi E, Samet JH. A Transitional Opioid Program to Engage Hospitalized Drug Users. J Gen Intern Med. 25(8):803-808. doi:https:\/\/doi.org\/10.1007\/s11606-010-1311-3","DOI":"10.1007\/s11606-010-1311-3"},{"key":"5920_CR4","doi-asserted-by":"publisher","unstructured":"Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and Opioid-Involved Overdose Deaths \u2014 United States, 2013\u20132017. MMWR Morb Mortal Wkly Rep. 2018;67(5152). doi:https:\/\/doi.org\/10.15585\/mmwr.mm6751521e1","DOI":"10.15585\/mmwr.mm6751521e1"},{"issue":"5","key":"5920_CR5","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","volume":"35","author":"MV Ronan","year":"2016","unstructured":"Ronan M V., Herzig SJ. Hospitalizations Related To Opioid Abuse\/Dependence And Associated Serious Infections Increased Sharply, 2002\u201312. Health Aff. 2016;35(5):832-837. doi:https:\/\/doi.org\/10.1377\/hlthaff.2015.1424","journal-title":"Health Aff."},{"issue":"5","key":"5920_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.amjmed.2015.09.024","volume":"129","author":"ES Rosenthal","year":"2016","unstructured":"Rosenthal ES, Karchmer AW, Theisen-Toupal J, Castillo RA, Rowley CF. Suboptimal Addiction Interventions for Patients Hospitalized with Injection Drug Use-Associated Infective Endocarditis. Am J Med. 2016;129(5):481-485. doi:https:\/\/doi.org\/10.1016\/j.amjmed.2015.09.024","journal-title":"Am J Med."},{"key":"5920_CR7","unstructured":"Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63, Full Document. Rockville, MD; 2018."},{"issue":"3","key":"5920_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle MR, Bernson D, Land T, et al. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality. Ann Intern Med. 2018;169(3):137. doi:https:\/\/doi.org\/10.7326\/M17-3107","journal-title":"Ann Intern Med."},{"key":"5920_CR9","doi-asserted-by":"publisher","unstructured":"Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357. doi:https:\/\/doi.org\/10.1136\/bmj.j1550","DOI":"10.1136\/bmj.j1550"},{"key":"5920_CR10","doi-asserted-by":"publisher","unstructured":"Ti L, Ti L. Leaving the hospital against medical advice among people who use illicit drugs: A systematic review. Am J Public Health. 2015;105(12). doi:https:\/\/doi.org\/10.2105\/AJPH.2015.302885","DOI":"10.2105\/AJPH.2015.302885"},{"key":"5920_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/J.SOCSCIMED.2014.01.010","volume":"105","author":"R McNeil","year":"2014","unstructured":"McNeil R, Small W, Wood E, Kerr T. Hospitals as a \u2018risk environment\u2019: An ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Soc Sci Med. 2014;105:59-66. doi:https:\/\/doi.org\/10.1016\/J.SOCSCIMED.2014.01.010","journal-title":"Soc Sci Med."},{"key":"5920_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/J.DRUGALCDEP.2018.06.010","volume":"190","author":"PJ Summers","year":"2018","unstructured":"Summers PJ, Hellman JL, MacLean MR, Rees VW, Wilkes MS. Negative experiences of pain and withdrawal create barriers to abscess care for people who inject heroin. A mixed methods analysis. Drug Alcohol Depend. 2018;190:200-208. doi:https:\/\/doi.org\/10.1016\/J.DRUGALCDEP.2018.06.010","journal-title":"Drug Alcohol Depend."},{"key":"5920_CR13","doi-asserted-by":"publisher","unstructured":"Marks LR, Munigala S, Warren DK, Liang SY, Schwarz ES, Durkin MJ. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis. 2018. doi:https:\/\/doi.org\/10.1093\/cid\/ciy924","DOI":"10.1093\/cid\/ciy924"},{"issue":"1","key":"5920_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","volume":"35","author":"C Timko","year":"2016","unstructured":"Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C. Retention in medication-assisted treatment for opiate dependence: A systematic review. J Addict Dis. 2016;35(1):22-35. doi:https:\/\/doi.org\/10.1080\/10550887.2016.1100960","journal-title":"J Addict Dis."},{"key":"5920_CR15","unstructured":"British Columbia Centre on Substance Use and British Columbia Ministry of Health. A Guideline for the Clinical Management of Opioid Use Disorder. 2017."},{"key":"5920_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","volume":"79","author":"P Trowbridge","year":"2017","unstructured":"Trowbridge P, Weinstein ZM, Kerensky T, et al. Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1-5. doi:https:\/\/doi.org\/10.1016\/j.jsat.2017.05.007","journal-title":"J Subst Abuse Treat."},{"issue":"8","key":"5920_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","volume":"32","author":"SE Wakeman","year":"2017","unstructured":"Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient Addiction Consultation for Hospitalized Patients Increases Post-Discharge Abstinence and Reduces Addiction Severity. J Gen Intern Med. 2017;32(8):909-916. doi:https:\/\/doi.org\/10.1007\/s11606-017-4077-z","journal-title":"J Gen Intern Med."},{"key":"5920_CR18","doi-asserted-by":"publisher","unstructured":"Priest KC, Gorfinkel L, Klimas J, Jones AA, Fairbairn N, McCarty D. Comparing Canadian and United States opioid agonist therapy policies. Int J Drug Policy. February 2019. doi:https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.020","DOI":"10.1016\/j.drugpo.2019.01.020"},{"issue":"9","key":"5920_CR19","doi-asserted-by":"publisher","first-page":"E247","DOI":"10.1503\/cmaj.170958","volume":"190","author":"J Bruneau","year":"2018","unstructured":"Bruneau J, Ahamad K, Goyer M-\u00c8, et al. Management of opioid use disorders: a national clinical practice guideline. Can Med Assoc J. 2018;190(9):E247-E257. doi:https:\/\/doi.org\/10.1503\/cmaj.170958","journal-title":"Can Med Assoc J."},{"key":"5920_CR20","unstructured":"British Columbia Centre on Substance Use and British Columbia Ministry of Health. Guidance for Injectable Opioid Agonist Treatment for Opioid Use Disorder.; 2017."},{"key":"5920_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","volume":"46","author":"N Fairbairn","year":"2017","unstructured":"Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172-179. doi:https:\/\/doi.org\/10.1016\/j.drugpo.2017.06.005","journal-title":"Int J Drug Policy."},{"issue":"8","key":"5920_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1176\/appi.ajp.2016.16070792","volume":"174","author":"KM Carroll","year":"2017","unstructured":"Carroll KM, Weiss RD. The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. Am J Psychiatry. 2017;174(8):738-747. doi:https:\/\/doi.org\/10.1176\/appi.ajp.2016.16070792","journal-title":"Am J Psychiatry."},{"issue":"1","key":"5920_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13722-019-0158-0","volume":"14","author":"P Bach","year":"2019","unstructured":"Bach P, Hartung D. Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders. Addict Sci Clin Pract. 2019;14(1):30. doi:https:\/\/doi.org\/10.1186\/s13722-019-0158-0","journal-title":"Addict Sci Clin Pract."},{"key":"5920_CR24","unstructured":"College of Pharmacists of British Columbia. Annual Report: 2017\/2018 Licensure Statistics.; 2018."},{"key":"5920_CR25","unstructured":"Ministry of Mental Health and Addictions BC. Responding to B.C.\u2019s Illegal Drug Overdose Epidemic: Progress Update.; 2018."},{"issue":"1","key":"5920_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0376-8716(03)00190-x","volume":"72","author":"TB Mitchell","year":"2003","unstructured":"Mitchell TB, White JM, Somogyi AA, Bochner F. Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence. Drug Alcohol Depend. 2003;72(1):85-94. doi:https:\/\/doi.org\/10.1016\/s0376-8716(03)00190-x","journal-title":"Drug Alcohol Depend."},{"key":"5920_CR27","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Austria Drug Report 2018.; 2018."},{"issue":"4","key":"5920_CR28","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jpain.2007.11.009","volume":"9","author":"F Johnson","year":"2008","unstructured":"Johnson F, Wagner G, Sun S, Stauffer J. Effect of Concomitant Ingestion of Alcohol on the In Vivo Pharmacokinetics of KADIAN (Morphine Sulfate Extended-Release) Capsules. J Pain. 2008;9(4):330-336. doi:https:\/\/doi.org\/10.1016\/j.jpain.2007.11.009","journal-title":"J Pain."},{"issue":"4","key":"5920_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025799","volume":"9","author":"J Klimas","year":"2019","unstructured":"Klimas J, Gorfinkel L, Giacomuzzi SM, et al. Slow release oral morphine versus methadone for the treatment of opioid use disorder. BMJ Open. 2019;9(4):e025799. doi:https:\/\/doi.org\/10.1136\/bmjopen-2018-025799","journal-title":"BMJ Open."},{"issue":"2","key":"5920_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/jcp.0000000000000288","volume":"35","author":"L Falcato","year":"2015","unstructured":"Falcato L, Beck T, Reimer J, Verthein U. Self-Reported Cravings for Heroin and Cocaine During Maintenance Treatment With Slow-Release Oral Morphine Compared With Methadone. J Clin Psychopharmacol. 2015;35(2):150-157. doi:https:\/\/doi.org\/10.1097\/jcp.0000000000000288","journal-title":"J Clin Psychopharmacol."},{"issue":"4","key":"5920_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jsat.2014.05.012","volume":"47","author":"R H\u00e4mmig","year":"2014","unstructured":"H\u00e4mmig R, K\u00f6hler W, Bonorden-Kleij K, et al. Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence. J Subst Abuse Treat. 2014;47(4):275-281. doi:https:\/\/doi.org\/10.1016\/j.jsat.2014.05.012","journal-title":"J Subst Abuse Treat."},{"issue":"8","key":"5920_CR32","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1360-0443.2005.001128.x","volume":"100","author":"H Eder","year":"2005","unstructured":"Eder H, Jagsch R, Kraigher D, Primorac A, Ebner N, Fischer G. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction. 2005;100(8):1101-1109. doi:https:\/\/doi.org\/10.1111\/j.1360-0443.2005.001128.x","journal-title":"Addiction."},{"issue":"11","key":"5920_CR33","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1111\/j.1360-0443.2008.02334.x","volume":"103","author":"A Kastelic","year":"2008","unstructured":"Kastelic A, Dubajic G, Strbad E. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression. Addiction. 2008;103(11):1837-1846. doi:https:\/\/doi.org\/10.1111\/j.1360-0443.2008.02334.x","journal-title":"Addiction."},{"issue":"8","key":"5920_CR34","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/j.1360-0443.2004.00764.x","volume":"99","author":"TB Mitchell","year":"2004","unstructured":"Mitchell TB, White JM, Somogyi AA, Bochner F. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence. Addiction. 2004;99(8):940-945. doi:https:\/\/doi.org\/10.1111\/j.1360-0443.2004.00764.x","journal-title":"Addiction."},{"issue":"2","key":"5920_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/10826080500391845","volume":"41","author":"S Giacomuzzi","year":"2006","unstructured":"Giacomuzzi S, Kemmler G, Ertl M, Riemer Y. Opioid Addicts at Admission vs. Slow-Release Oral Morphine, Methadone, and Sublingual Buprenorphine Maintenance Treatment Participants. Subst Use Misuse. 2006;41(2):223-244. doi:https:\/\/doi.org\/10.1080\/10826080500391845","journal-title":"Subst Use Misuse."},{"issue":"2","key":"5920_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000368572","volume":"21","author":"U Verthein","year":"2014","unstructured":"Verthein U, Beck T, Haasen C, Reimer J. Mental Symptoms and Drug Use in Maintenance Treatment with Slow-Release Oral Morphine Compared to Methadone: Results of a Randomized Crossover Study. Eur Addict Res. 2014;21(2):97-104. doi:https:\/\/doi.org\/10.1159\/000368572","journal-title":"Eur Addict Res."},{"key":"5920_CR37","doi-asserted-by":"publisher","unstructured":"Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin-dependent individuals. Cochrane Database Syst Rev. 2011. doi:https:\/\/doi.org\/10.1002\/14651858.CD003410.pub4","DOI":"10.1002\/14651858.CD003410.pub4"},{"issue":"3","key":"5920_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.drugalcdep.2010.06.009","volume":"112","author":"A Karow","year":"2010","unstructured":"Karow A, Reimer J, Sch\u00e4fer I, Krausz M, Haasen C, Verthein U. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence. Drug Alcohol Depend. 2010;112(3):209-215. doi:https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.06.009","journal-title":"Drug Alcohol Depend."},{"key":"5920_CR39","doi-asserted-by":"publisher","unstructured":"Marchand KI, Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Schechter MT. Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency. BMC Health Serv Res. 2011;11(1). doi:https:\/\/doi.org\/10.1186\/1472-6963-11-174","DOI":"10.1186\/1472-6963-11-174"},{"issue":"5","key":"5920_CR40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","volume":"73","author":"E Oviedo-Joekes","year":"2016","unstructured":"Oviedo-Joekes E, Guh D, Brissette S, et al. Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence. JAMA Psychiatry. 2016;73(5):447. doi:https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.0109","journal-title":"JAMA Psychiatry."},{"issue":"5","key":"5920_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1192\/bjp.bp.112.111583","volume":"203","author":"S Byford","year":"2013","unstructured":"Byford S, Barrett B, Metrebian N, et al. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction. Br J Psychiatry. 2013;203(5):341-349. doi:https:\/\/doi.org\/10.1192\/bjp.bp.112.111583","journal-title":"Br J Psychiatry."},{"issue":"6","key":"5920_CR42","doi-asserted-by":"publisher","first-page":"E317","DOI":"10.1503\/cmaj.110669","volume":"184","author":"B Nosyk","year":"2012","unstructured":"Nosyk B, Guh DP, Bansback NJ, et al. Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment. Can Med Assoc J. 2012;184(6):E317-E328. doi:https:\/\/doi.org\/10.1503\/cmaj.110669","journal-title":"Can Med Assoc J."},{"issue":"7503","key":"5920_CR43","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/bmj.330.7503.1297","volume":"330","author":"MGW Dijkgraaf","year":"2005","unstructured":"Dijkgraaf MGW, van der Zanden BP, de Borgie CAJM, Blanken P, van Ree JM, van den Brink W. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ. 2005;330(7503):1297. doi:https:\/\/doi.org\/10.1136\/bmj.330.7503.1297","journal-title":"BMJ."},{"issue":"7","key":"5920_CR44","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/add.14171","volume":"113","author":"N Bansback","year":"2018","unstructured":"Bansback N, Guh D, Oviedo-Joekes E, et al. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial. Addiction. 2018;113(7):1264-1273. doi:https:\/\/doi.org\/10.1111\/add.14171","journal-title":"Addiction."},{"issue":"1","key":"5920_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12954-017-0163-0","volume":"14","author":"M Sharma","year":"2017","unstructured":"Sharma M, Lamba W, Cauderella A, Guimond TH, Bayoumi AM. Harm reduction in hospitals. Harm Reduct J. 2017;14(1):32. doi:https:\/\/doi.org\/10.1186\/s12954-017-0163-0","journal-title":"Harm Reduct J."},{"key":"5920_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1477-7517-6-19","volume":"6","author":"BS Rachlis","year":"2009","unstructured":"Rachlis BS, Kerr T, Montaner JSG, Wood E. Harm reduction in hospitals: is it time? Harm Reduct J. 2009;6:19. doi:https:\/\/doi.org\/10.1186\/1477-7517-6-19","journal-title":"Harm Reduct J."},{"key":"5920_CR47","unstructured":"Opioid & Health Indicators Database. https:\/\/opioid.amfar.org\/indicator\/num_SSPs. Accessed December 17, 2019."},{"key":"5920_CR48","doi-asserted-by":"publisher","unstructured":"Brooks HL, O\u2019Brien DC, Salvalaggio G, Dong K, Hyshka E. Uptake into a bedside needle and syringe program for acute care inpatients who inject drugs. Drug Alcohol Rev. April 2019:dar.12930. doi:https:\/\/doi.org\/10.1111\/dar.12930","DOI":"10.1111\/dar.12930"},{"key":"5920_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","volume":"145","author":"C Potier","year":"2014","unstructured":"Potier C, Lapr\u00e9vote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: What has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48-68. doi:https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.10.012","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"5920_CR50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jhm.2344","volume":"10","author":"L Ti","year":"2015","unstructured":"Ti L, Buxton J, Harrison S, et al. Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs. J Hosp Med. 2015;10(5):301-306. doi:https:\/\/doi.org\/10.1002\/jhm.2344","journal-title":"J Hosp Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05920-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-020-05920-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05920-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:08:31Z","timestamp":1622074111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-020-05920-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["5920"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-05920-0","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"28 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}